Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700130 | Clinical Oncology | 2007 | 7 Pages |
Abstract
Chemotherapy use is common in SBA. Our data and available published studies suggest that chemotherapy may provide benefit, but the optimal chemotherapy regimen and the degree of benefit remain to be defined. A sound approach to investigate the management of rare malignancies is desperately needed.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
P. Czaykowski, D. Hui,